Figure 10.
Schematic representation of the modulation of serine racemase expression functioning via mTOR and ERK pathways. Abbreviations: Ket, (R,S)-ketamine; NorKet, (R,S)-norketamine; HNK, (2S,6S)-hydroxynorketamine; nAchR, nicotinic acetylcholine receptor; mTORC1, mammalian target of rapamycin complex 1; mTORC2, mammalian target of rapamycin complex 2; SR, serine racemase.